249 related articles for article (PubMed ID: 25426437)
1. Investigation of moxifloxacin loaded chitosan-dextran nanoparticles for topical instillation into eye: In-vitro and ex-vivo evaluation.
Kaskoos RA
Int J Pharm Investig; 2014 Oct; 4(4):164-73. PubMed ID: 25426437
[TBL] [Abstract][Full Text] [Related]
2. Chondroitin sulfate-chitosan nanoparticles for ocular delivery of bromfenac sodium: Improved permeation, retention, and penetration.
Abdullah TA; Ibrahim NJ; Warsi MH
Int J Pharm Investig; 2016; 6(2):96-105. PubMed ID: 27051629
[TBL] [Abstract][Full Text] [Related]
3. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
[TBL] [Abstract][Full Text] [Related]
4. Mucoadhesive chitosan-dextran sulfate nanoparticles for sustained drug delivery to the ocular surface.
Chaiyasan W; Srinivas SP; Tiyaboonchai W
J Ocul Pharmacol Ther; 2013 Mar; 29(2):200-7. PubMed ID: 23356788
[TBL] [Abstract][Full Text] [Related]
5. An Ex Vivo Evaluation of Moxifloxacin Nanostructured Lipid Carrier Enriched In Situ Gel for Transcorneal Permeation on Goat Cornea.
Gade S; Patel KK; Gupta C; Anjum MM; Deepika D; Agrawal AK; Singh S
J Pharm Sci; 2019 Sep; 108(9):2905-2916. PubMed ID: 30978345
[TBL] [Abstract][Full Text] [Related]
6. Hydroxypropyl methacrylamide-based copolymeric nanoparticles loaded with moxifloxacin as a mucoadhesive, cornea-penetrating nanomedicine eye drop with enhanced therapeutic benefits in bacterial keratitis.
Ch S; Mishra P; Bhatt H; Ghosh B; Roy S; Biswas S
Colloids Surf B Biointerfaces; 2021 Dec; 208():112113. PubMed ID: 34562784
[TBL] [Abstract][Full Text] [Related]
7. Moxifloxacin Hydrochloride-Loaded Eudragit® RL 100 and Kollidon® SR Based Nanoparticles: Formulation, In vitro Characterization and Cytotoxicity.
Kırımlıoğlu GY; Özer S; Büyükköroğlu G; Yazan Y
Comb Chem High Throughput Screen; 2021; 24(3):328-341. PubMed ID: 32342810
[TBL] [Abstract][Full Text] [Related]
8. Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development,
Kaul S; Jain N; Pandey J; Nagaich U
Recent Pat Antiinfect Drug Discov; 2020; 15(1):41-67. PubMed ID: 31612834
[TBL] [Abstract][Full Text] [Related]
9. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
10. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of gatifloxacin pluronic micelles and development of its formulation for ocular delivery.
Kanoujia J; Kushwaha PS; Saraf SA
Drug Deliv Transl Res; 2014 Aug; 4(4):334-43. PubMed ID: 25787066
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Ocular Efficacy of Levofloxacin by Bioadhesive Chitosan Coated PLGA Nanoparticles: Box-behnken Design,
Ameeduzzafar ; Khan N; Alruwaili NK; Bukhari SNA; Alsuwayt B; Afzal M; Akhter S; Yasir M; Elmowafy M; Shalaby K; Ali A
Iran J Pharm Res; 2020; 19(1):292-311. PubMed ID: 32922488
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
15. Formulation and corneal permeation of ketorolac tromethamine-loaded chitosan nanoparticles.
Fathalla ZM; Khaled KA; Hussein AK; Alany RG; Vangala A
Drug Dev Ind Pharm; 2016; 42(4):514-24. PubMed ID: 26407208
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/β-glycerophosphate in situ forming thermo-sensitive hydrogel for improved ocular delivery of moxifloxacin hydrochloride.
Asfour MH; Abd El-Alim SH; Awad GEA; Kassem AA
Eur J Pharm Sci; 2021 Dec; 167():106041. PubMed ID: 34655737
[TBL] [Abstract][Full Text] [Related]
17. Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections.
Youssef AAA; Thakkar R; Senapati S; Joshi PH; Dudhipala N; Majumdar S
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745818
[TBL] [Abstract][Full Text] [Related]
18. Chitosan-coated PLGA nanoparticles of bevacizumab as novel drug delivery to target retina: optimization, characterization, and in vitro toxicity evaluation.
Pandit J; Sultana Y; Aqil M
Artif Cells Nanomed Biotechnol; 2017 Nov; 45(7):1397-1407. PubMed ID: 27855494
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of tapentadol hydrochloride-loaded chitosan nanoparticles: formulation, characterisation and its in vivo evaluation.
Javia A; Thakkar H
J Microencapsul; 2017 Nov; 34(7):644-658. PubMed ID: 28862072
[TBL] [Abstract][Full Text] [Related]
20. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
